ArticleFrontiers in oncology2026
Integrative oncology: evolution, framework, and future directions.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past several decades, cancer treatment has evolved from a discipline centered almost exclusively on tumor-directed modalities to one that increasingly acknowledges the complex interplay of biological, behavioral, psychosocial, spiritual, cultural, and environmental factors that shape patient outcomes. This shift has set the stage for the rise of integrative oncology: an evidence-informed, patient-centered approach that combines mind-body practices, natural products, and lifestyle strategies with conventional cancer treatment to enhance wellbeing, manage symptoms, and improve quality of life across the cancer continuum. Although rooted in long-standing healing traditions, integrative oncology emerged as a modern clinical and scientific field in response to patient needs, health-belief models, growing research evidence, and recognition of the limitations of a purely biomedical framework. There is also a need to mitigate the risks associated with unmonitored "alternative medicine" use and to ensure that trained healthcare professionals foster open, non-judgmental, evidence-based, patient-centered discussions regarding the use of integrative modalities in high-risk oncology and surgical settings. The formation of the Society for Integrative Oncology, development of evidence-informed clinical guidelines, and increasing adoption within major cancer centers have collectively advanced the discipline and established standards for safe and effective care. As the field matures, challenges remain including disparities in access, gaps in education, and the need for rigorous whole-systems research. This introductory manuscript to the special issue outlines the historical trajectory, scientific foundations, clinical models, and future opportunities that define integrative oncology today and its potential to transform cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.